EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Air Pollutants and Breast Cancer Risk: A Parallel Analysis of Five Large US Prospective Cohorts

Alexandra J. White, Jaime E. Hart, Sabah M. Quraishi, Deborah B. Bookwalter, Marina R. Sweeney, Elizabeth W. Spalt, Michael S. Hendryx, Veronica L. Irvin, Dorothy S. Lane, Aladdin H. Shadyab, Shawnita Sealy-Jefferson, Marian L. Neuhouser, Eric A. Whitsel, Joel D. Kaufman, Francine Laden, Dale P. Sandler

American Journal of Public Health · 2025-12 · 115 (12) · 2030-2043

DOI: 10.2105/ajph.2025.308247 ↗
AbstractBibliografische Angaben

Abstract

Objectives. To determine whether outdoor air pollution exposure is associated with breast cancer incidence. Methods. Residential-level concentrations of nitrogen dioxide (NO 2 , parts per billion [ppb]), fine particulate matter (PM 2.5 ; ≤ 2.5 μ/m 3 ) and ozone (ppb) in the United States were estimated for participants of the Nurses’ Health Studies, Women’s Health Initiative Clinical Trials and Observational Study Cohort, and Sister Study using high-resolution spatiotemporal models. Cox proportional hazards regression estimated cohort-specific hazard ratios (HRs) and 95% confidence intervals (CIs), and a random effects model determined summary HRs, overall and by estrogen receptor (ER)/progesterone receptor (PR) subtype and census region. Results. NO 2 was positively associated with overall breast cancer incidence (n = 28 811 cases; HR = 1.03; 95% CI = 1.00, 1.05), with little variation by subgroups. PM 2.5 was associated with higher incidence of ER-/PR- tumors (n = 2367 cases; HR = 1.14; 95% CI = 1.04, 1.24; P-heterogeneity < .001) and with higher overall incidence in the Midwest (HR = 1.15; 95% CI = 1.01, 1.32; P-heterogeneity = .01). Ozone was not associated with overall incidence, but was associated with ER-/PR- tumors (n = 3406 cases; HR = 1.10; 95% CI = 1.00, 1.21; P-heterogeneity = .03). Conclusions. In this largest US study to date, we confirmed an association between NO 2 and breast cancer, and we present novel associations of PM 2.5 and ozone with ER-/PR- tumors. ( Am J Public Health. 2025;115(12): 2030–2043. https://doi.org/10.2105/AJPH.2025.308247 )

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →